Sun Pharma (Tamlet)
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer of medical drugs. The company is engaged in the development and production of the Tamsulosin+Tolterodine products used for the treatment of men with lower urinary tract symptoms and overactive bladder.
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- SUN HOUSE, CTS No. 201 B/1
- Western Express Highway, Goregaon (East)
- Mumbai, Maharashtra 400063
- India
Sun Pharma (Tamlet) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Sun Pharma (Tamlet)‘s full profile, request access.
Request full access to PitchBookSun Pharma (Tamlet) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Sun Pharma (Tamlet)‘s full profile, request access.
Request full access to PitchBook